Literature DB >> 9627160

Risk factor clustering in patients with hypertension and non-insulin-dependent diabetes mellitus. The Skaraborg Hypertension Project.

E Bøg-Hansen1, U Lindblad, K Bengtsson, J Ranstam, A Melander, L Råstam.   

Abstract

OBJECTIVES: To assess the coexistence of hypertension and diabetes, associations with cardiovascular risk factors and the achievement of current treatment goals.
DESIGN: A community-based, cross-sectional, observational study.
SETTING: Hypertension and diabetes outpatient clinics in primary health care, Skara, Sweden.
SUBJECTS: All patients (n = 1116; 488 men, 628 women) who performed an annual follow-up from May 1992 to September 1993. MAIN OUTCOME MEASURES: Hypertension, non-insulin-dependent diabetes mellitus (NIDDM), blood pressure, fasting B-glucose, lipids, HbAlc, body mass index (BMI), waist hip ratio (WHR).
RESULTS: Hypertension alone was found in 286 men and 430 women, hypertension and NIDDM combined in 102 men and 102 women, and NIDDM alone in 100 men and 96 women. Taking new cases into account, the proportion of hypertension among NIDDM patients was 57%, and the proportion of NIDDM among hypertensives was 26%. Men and women with both hypertension and NIDDM had a higher systolic blood pressure and women also had a higher diastolic blood pressure (men 168/88 mmHg, women 165/86 mmHg) than those with hypertension alone (men 152/87 mmHg, women 156/82 mmHg) (P < or = 0.001). Cardiovascular risk factors accumulated in patients with both hypertension and NIDDM (triglycerides, BMI and WHR). A diastolic blood pressure < or = 90 mmHg was achieved by 71% men and 84% women with hypertension. HbAlc < 7.5% was attained by 71% men and 70% women with NIDDM.
CONCLUSIONS: A considerable coexistence of hypertension and NIDDM was demonstrated. Cardiovascular risk factors clustered in patients with both diseases and their blood pressure was less controlled. These patients thus comprised a clinically defined group at high risk. By current guidelines, control of hypertension and NIDDM seemed appropriate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627160     DOI: 10.1046/j.1365-2796.1998.00286.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  13 in total

Review 1.  Earlier management of subjects who are prone to hypertension and diabetes mellitus.

Authors:  Hiromi Rakugi; Toshio Ogihara
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

2.  HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction.

Authors:  Anne-Lise Paisible; Chung-Chou H Chang; Kaku A So-Armah; Adeel A Butt; David A Leaf; Matthew Budoff; David Rimland; Roger Bedimo; Matthew B Goetz; Maria C Rodriguez-Barradas; Heidi M Crane; Cynthia L Gibert; Sheldon T Brown; Hilary A Tindle; Alberta L Warner; Charles Alcorn; Melissa Skanderson; Amy C Justice; Matthew S Freiberg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-01       Impact factor: 3.731

3.  Effect of the peroxisome proliferator-activated receptor-gamma C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus.

Authors:  V Tavares; R D C Hirata; A C Rodrigues; O Monte; J E N Salles; N Scallissi; A C Speranza; S Gomes; M H Hirata
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

4.  β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis.

Authors:  Hao Wang; Jielin Liu; Kuo Liu; Ya Liu; Zuoguang Wang; Yuqing Lou; Qiuli Niu; Wei Gu; Lijuan Wang; Mei Li; Xiaoling Zhu; Shaojun Wen
Journal:  Mol Biol Rep       Date:  2013-04-16       Impact factor: 2.316

5.  Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. The Skaraborg Hypertension and Diabetes Project.

Authors:  Anita Mehner; Ulf Lindblad; Lennart Råstam; Kristina Bengtsson Boström
Journal:  Eur J Clin Pharmacol       Date:  2008-04-04       Impact factor: 2.953

6.  Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care: a population-based follow-up study in the Skaraborg Project.

Authors:  Erik Bøg-Hansen; Charlotte A Larsson; Bo Gullberg; Arne Melander; Kristina Boström; Lennart Råstam; Ulf Lindblad
Journal:  Scand J Prim Health Care       Date:  2007-12       Impact factor: 2.581

7.  Polymorphisms in α- and β-Adrenergic Receptor Genes, Hypertension, and Obstructive Sleep Apnea: The Skaraborg Sleep Study.

Authors:  Kristina Bengtsson Boström; Jan Hedner; Ludger Grote; Olle Melander; Fredrik von Wowern; Lennart Råstam; Leif Groop; Ulf Lindblad
Journal:  Int J Hypertens       Date:  2010-03-30       Impact factor: 2.420

8.  Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.

Authors:  Marju Orho-Melander; Olle Melander; Candace Guiducci; Pablo Perez-Martinez; Dolores Corella; Charlotta Roos; Ryan Tewhey; Mark J Rieder; Jennifer Hall; Goncalo Abecasis; E Shyong Tai; Cullan Welch; Donna K Arnett; Valeriya Lyssenko; Eero Lindholm; Richa Saxena; Paul I W de Bakker; Noel Burtt; Benjamin F Voight; Joel N Hirschhorn; Katherine L Tucker; Thomas Hedner; Tiinamaija Tuomi; Bo Isomaa; Karl-Fredrik Eriksson; Marja-Riitta Taskinen; Björn Wahlstrand; Thomas E Hughes; Laurence D Parnell; Chao-Qiang Lai; Göran Berglund; Leena Peltonen; Erkki Vartiainen; Pekka Jousilahti; Aki S Havulinna; Veikko Salomaa; Peter Nilsson; Leif Groop; David Altshuler; Jose M Ordovas; Sekar Kathiresan
Journal:  Diabetes       Date:  2008-08-04       Impact factor: 9.461

9.  Multilevel analysis of systolic blood pressure and ACE gene I/D polymorphism in 438 Swedish families--a public health perspective.

Authors:  Juan Merlo; Kristina Bengtsson-Boström; Ulf Lindblad; Lennart Råstam; Olle Melander
Journal:  BMC Med Genet       Date:  2006-03-01       Impact factor: 2.103

10.  The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus.

Authors:  Jacob Odeberg; Charlotte A Larsson; Lennart Råstam; Ulf Lindblad
Journal:  BMC Cardiovasc Disord       Date:  2008-12-10       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.